Introduction {#sec1}
============

The endocannabinoid system plays a pivotal role in maintaining various physiological and pathological processes. G-protein coupled cannabinoid receptor (CB~1~ and CB~2~) systems have been identified as cannabinoid targets. These receptors have significant implications in various pathophysiologies that include neurodegenerative diseases, eating disorders, pain, inflammation, and cancer.^[@ref1]^ Consequently, the identification of new structural scaffolds that can bind to the cannabinoid receptors remains an active research. Fatty acid amides (consists of a fatty acid chain and a peptide moiety), isolated mainly from marine cyanobacteria, represent a potential cannabinoid receptor ligands. Among them, serinolamide A **1**, a new marine natural product, was recently isolated from cyanobacteria *Lyngbya majuscula* collected in Papua, New Guinea.^[@ref2]^ Serinolamide A **1** exhibits a moderate agonist effect and selectivity toward the CB~1~ cannabinoid receptor. This endocannabinoid lipid shows excellent structural features with a long chain fatty acid attached to the serinol derivative, allowing maximum diversity for the search of more potent candidates. Very recently, two more chlorinated fatty acid amides such as columbamide D and E have been isolated from the marine cyanobacterium *Moorea bouillonii*that can be structurally related to serinolamide A **1**. Importantly, these compounds exhibit moderate cytotoxic activity against MCF7 breast and H460 lung cancer cells.^[@ref3]^ Because of their unique structural features combined with promising biological profiles of these fatty acid amides, in particular, serinolamide A **1** and columbamide D **2** have now became an important target for synthetic chemists ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).

![Selected examples of fatty acid amides from marine cyanobacteria with binding affinities to cannabinoid receptors.](ao-2018-03417c_0001){#fig1}

Very few syntheses of serinolamide A **1** are available till date. The first synthesis reported was the chiral pool approach starting from [l]{.smallcaps}-serine which comprises more number of steps and an overall yield of 30%.^[@ref4]^ Although the above-mentioned synthesis was accomplished with a good overall yield, the number of steps and the use of expensive reagents limit its use for the large-scale synthesis. For an example, the O-methylation step of this route requires the usage of excess of expensive silver oxide with prolonged reaction period. Very recently, a new enantioselective route for the synthesis of serinolamide A **1** has been developed employing palladium-catalyzed DYKAT strategy.^[@ref5]^ This method appears to be attractive because of the less number of steps with an overall yield of 51%; however, this approach requires more protection/deprotection sequences. Similarly, there is only one report available for the preparation of columbamide D **2**, employing the enantioselective installation of chlorine atom using MacMillan's condition as a key step.^[@cit3a]^ However quite long synthetic steps are required to accomplish the synthesis of **2** using this strategy. Therefore, the development of a robust method that can provide facile access to **1** and **2**, especially from a common intermediate, is highly attractive and desirable. In this context, as a part of our ongoing program aimed at utilizing terminal epoxides for the synthesis of various pharmaceutically important compounds,^[@ref6],[@ref7]^ we herein report an efficient synthetic strategy toward the total synthesis of serinolamide A **1** and columbamide D **2**.

Results and Discussion {#sec2}
======================

A retrosynthetic analysis of **1** and **2** is based on a convergent approach, as depicted in [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}. It is envisaged that fragment (*R*)-**7** would serve as a common intermediate for the synthesis of both the target compounds **1** and **2**. The key fragment (*R*)-**7** could be achieved easily from commercially available (*R*)-benzyl glycidyl ether (*R*)-**3** via epoxide opening and Mitsunobu protocols. Synthesis of **1** could be carried out by coupling (*R*)-**7** with another acid partner **12**. Acid fragment **12** can be accessed from alcohol **8** through oxidation, Grignard reaction, and Johnson--Claisen rearrangement.^[@ref8]^ Similarly, target **2** could be achieved by coupling between the two fragments that is alcohol (*R*)-**7** and acid **21**. Compound **21**, in turn, could be obtained from olefin **13** via Appel reaction, cross-metathesis, hydrolytic kinetic resolution (HKR), and so forth, as key steps.

![Retrosynthetic Analysis of **1** and **2**](ao-2018-03417c_0002){#sch1}

Accordingly, we first chose to prepare the key component (*R*)-**7**, which is a common precursor for both serinolamide A **1** and columbamide D **2** ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). Commercially available (*R*)-benzyl glycidyl ether (*R*)-**3** was regioselectively opened using methanol under basic conditions to get the protected triol (*R*)-**4**. Here, it is worth mentioning that this step of O-methylation is simple and straightforward as compared to the reported cumbersome protocol that involves the excess use of expensive silver oxide for O-methylation.^[@ref4]^ Now, the compound (*R*)-**4** on treatment with *N*-methyl-4-nitrobenzenesulfonamide employing Mitsunobu protocol afforded the amino alcohol (*S*)-**5**. Nosyl deprotection using thiophenol followed by hydrogenolysis afforded the key fragment (*R*)-**7**.

![Synthesis of Amino Alcohol Fragment (*R*)-**7**](ao-2018-03417c_0003){#sch2}

With the enantiopure amino alcohol (*R*)-**7** in hand, we diverted our attention toward the synthesis of fragment **12** that is required for the final coupling reaction to obtain serinolamide A **1** ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}). Thus, the commercially available tetradecanol **8** was first oxidized to get the corresponding aldehyde **9**, which on Grignard reaction with vinyl magnesium chloride afforded allyl alcohol **10**. Next, the intermediate **10** was heated with triethyl orthoacetate in a sealed tube to furnish ester **11**, followed by hydrolysis to accomplish the synthesis of the required acid fragment **12**.

![Synthesis of Fragment **12**](ao-2018-03417c_0004){#sch3}

Similarly, fragment **21** required for the preparation of columbamide D **2** was prepared in seven linear steps starting from 9-decen-1-ol **13** ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}). O-protection of compound **13** followed by epoxidation using *m*-CPBA afforded epoxide **15**. Obviously, the best option to induce chirality in terminal epoxide is the choice of the HKR strategy.^[@ref9]^ Therefore, the racemic epoxide was treated with Jacobsen's catalyst \[(*S*,*S*)-salen Co(III)-OAc\] in the presence of H~2~O to yield the required chiral epoxide **16a** and diol **16b** as a byproduct. Importantly, the undesired diol **16b** can be converted into the desired epoxide **16a** as per the reported procedure.^[@ref10]^ Epoxide **16a** underwent regioselective ring opening smoothly with pent-4-en-1-yl magnesium bromide, followed by silyl deprotection to afford diol **18**. Installation of chlorine atoms on C-7 and C-15 was achieved using Appel reaction and subsequent chain elongation, employing a cross-metathesis reaction between **19** and acid **20**, furnishing the required fragment **21**. It is important to mention here that we accomplished the synthesis of fragment **21** in simple 7 steps as compared to the lengthy 17 steps reported in the literature.^[@cit3a]^

![Synthesis of Fragment **21**](ao-2018-03417c_0005){#sch4}

After successful preparation of all of the required fragments, finally, we coupled the common precursor (*R*)-**7** with component **12** using EDC/HOBt to accomplish the synthesis of serinolamide A **1** ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}). Similarly, (*R*)-**7** was coupled with fragment **21** using the same reaction condition to furnish columbamide D **2**. The structures were confirmed by its ^1^H NMR, ^13^C NMR, and high-resolution mass spectrometry (HRMS) analysis. The enantiomeric purity of **1** was determined by chiral HPLC analysis (see the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b03417/suppl_file/ao8b03417_si_001.pdf)).

![Synthesis of **1** and **2**](ao-2018-03417c_0006){#sch5}

Conclusions {#sec3}
===========

In summary, we accomplished the total synthesis of two new naturally occurring fatty acid amides, that is, serinolamide A **1** and columbamide D **2**, in less number of steps and good overall yields. Further, both of these target compounds are obtained from a common precursor (*R*)-**7** in high optical purity. In addition, the acid fragment **21** was synthesized in 7 steps in good yield as compared to the reported 17 steps. We envisage that this simple protocol may find application for the large-scale synthesis of **1** and **2**, and the strategy could be exploited further for the preparation of newer analogues of **1** and **2** that can be utilized for extensive biological studies.

Experimental Section {#sec4}
====================

General Information {#sec4.1}
-------------------

Unless otherwise specified, all reactions were carried out in oven-dried vials or reaction vessels with magnetic stirring under argon atmosphere. Dried solvents and liquid reagents were transferred by oven-dried syringes or hypodermic syringe cooled to ambient temperature in desiccators. All experiments were monitored by analytical thin layer chromatography (TLC). TLC was performed on precoated silica gel plates. After elution, plate was visualized under UV illumination at 254 nm for UV active materials. Further visualization was achieved by staining anisaldehyde and charring on a hot plate. Solvents were removed in vacuo and heated with a water bath at 35 °C. Silica gel finer than 200 mesh was used for flash column chromatography. Columns were packed as a slurry of silica gel in pet. ether and equilibrated with the appropriate solvent mixture prior to use. The compounds were loaded neatly or used as a concentrated solution using the appropriate solvent system.

Melting points are uncorrected and recorded using digital BUCHI Melting Point Apparatus B-540. ^1^H NMR spectra and ^13^C NMR spectra were recorded on Bruker AV, 400/500 MHz spectrometers in appropriate solvents using TMS as the internal standard or solvent signals as secondary standards, and the chemical shifts are shown in δ scales. Multiplicities of ^1^H NMR signals are designated as s (singlet), d (doublet), dd (doublet of doublet), dt (doublet of triplet), t (triplet), quin (quintet), m (multiplet), and so forth. Optical rotations were measured using a JASCO P 1020 digital polarimeter. HRMS was performed on a TOF/Q-TOF mass spectrometer. Enantiomeric excess was determined by chiral HPLC.

(*R*)-1-(Benzyloxy)-3-methoxypropan-2-ol (*R*)-**4** {#sec4.2}
----------------------------------------------------

To a stirred solution of (*R*)-benzyl glycidyl ether (*R*)-**3** (3 g, 18.2 mmol) in methanol (30 mL) was slowly added powdered KOH (3 g; 51.5 mmol) at 10 °C, and the reaction mixture was stirred at ambient temperature for 6 h. After the completion of the reaction (indicated by TLC), the solvent was evaporated under reduced pressure. The residue was dissolved in ethyl acetate (50 mL), washed with water, dried over Na~2~SO~4~, and evaporated under reduced pressure. The crude product was purified by column chromatography (silica gel, petroleum ether/acetone, 90:10) to afford (*R*)-**4** (3.5 g, 98%) as a colorless oil; *R*~f~ = 0.4 (petroleum ether/acetone, 80:20). \[α\]~D~^25^ = +2.0 (*c* 1.55, EtOH); ^1^H NMR (400 MHz, CDCl~3~): δ~H~ 7.42--7.25 (m, 5H), 4.61--4.50 (m, 2H), 3.99 (dt, *J* = 2.0, 4.2 Hz, 1H), 3.58--3.49 (m, 2H), 3.49--3.40 (m, 2H), 3.38 (d, *J* = 2.0 Hz, 3H), 2.57 (br s, 1H); ^l3^C{^1^H} NMR (100 MHz, CDCl~3~): δ 137.9, 128.3, 127.7, 73.8, 73.4, 71.3, 69.3, 59.1; HRMS (ESI-TOF): calcd for C~11~H~16~O~3~Na \[M + Na\]^+^, 219.0992; found, 219.0989.

(*S*)-*N*-(1-(Benzyloxy)-3-methoxypropan-2-yl)-*N*-methyl-4-nitrobenzenesulfonamide (*S*)-**5** {#sec4.3}
-----------------------------------------------------------------------------------------------

A solution of DIAD (2.4 mL, 15.3 mmol) was added dropwise to a solution of (*R*)-**4** (2.0 g, 10.1 mmol), *N*-methyl-4-nitrobenzenesulfonamide (2.2 g, 10.1 mmol), and triphenyl phosphine (4 g, 15.3 mmol) in dry tetrahydrofuran (THF) (20 mL) at 0 °C under N~2~ atmosphere. Then, the reaction mixture was stirred at room temperature for 6 h. The solvent was removed under reduced pressure, and the residue was purified by column chromatography (silica gel, petroleum ether/EtOAc, 85:15) to afford (*S*)-**5** (3.7 g, 95%) as a yellow thick liquid; *R*~f~ = 0.3 (petroleum ether/EtOAc, 70:30). \[α\]~D~^25^ = −13.2 (*c* 1.0 CHCl~3~); ^1^H NMR (400 MHz, CDCl~3~): δ~H~ 8.10--8.02 (m, *J* = 8.3 Hz, 2H), 7.95--7.87 (m, *J* = 8.3 Hz, 2H), 7.26 (d, *J* = 2.4 Hz, 3H), 7.13--7.05 (m, 2H), 4.39--4.22 (m, 3H), 3.55 (d, *J* = 6.4 Hz, 2H), 3.52--3.43 (m, 2H), 3.20 (s, 3H), 2.87 (s, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ~C~ 149.4, 145.2, 137.2, 128.6, 128.3, 127.9, 127.8, 123.5, 73.3, 71.7, 68.4, 58.8, 56.6, 30.0; HRMS (ESI-TOF): calcd for C~18~H~22~O~6~N~2~SNa \[M + Na\]^+^, 417.109; found, 417.1083.

(*S*)-1-(Benzyloxy)-3-methoxy-*N*-methylpropan-2-amine (*S*)-**6** {#sec4.4}
------------------------------------------------------------------

To a solution of (*S*)-**5** (0.8 g, 2.0 mmol) in acetonitrile (15 mL) was added K~2~CO~3~ (0.33 g, 2.43 mmol) followed by thiophenol (0.06 mL, 0.6 mmol), and the reaction mixture was stirred at room temperature for 6 h. The solvent was evaporated under reduced pressure and the residue was dissolved in DCM (15 mL), washed with 1 M NaOH (10 mL), then with brine (10 mL), and dried over anhydrous Na~2~SO~4~. The solvent was evaporated under reduced pressure to afford the crude product which was purified by column chromatography (silica gel, DCM/MeOH, 97:03) to afford (*S*)-**6** (0.41 g, 98%) as a pale yellow liquid; *R*~f~ = 0.3 (DCM/MeOH, 90:10). \[α\]~D~^25^ = −56.7 (*c* 0.94 CHCl~3~); ^1^H NMR (400 MHz, CDCl~3~): δ~H~ 7.39--7.23 (m, 5H), 4.53 (s, 2H), 3.65--3.39 (m, 6H), 3.37--3.28 (m, 3H), 2.92--2.89 (m, 1H) 2.47 (s, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ~C~ 138.1, 128.3, 127.6, 73.3, 72.1, 69.5, 59.0, 58.8, 33.9; HRMS (ESI-TOF): calcd for C~12~H~20~O~2~N \[M\]^+^, 210.1489; found, 210.1486.

(*R*)-3-Methoxy-2-(methylamino)propan-1-ol (*R*)-**7** {#sec4.5}
------------------------------------------------------

To a solution of (*S*)-**6** (0.21 g, 1.0 mmol) in EtOH (3 mL) was added palladium hydroxide on activated charcoal (40 mg, 10--20 wt %), and the reaction mixture was stirred under hydrogen (20 psi) for 5 h. After the completion of the reaction (indicated by TLC), the catalyst was filtered over a plug of Celite bed (EtOAc eluent) and the solvent was evaporated under reduced pressure to yield (*R*)-**7** (0.11 g, 97%) as a pale yellow oil. \[α\]~D~^25^ = −2.1 (*c* 1.32 EtOH); ^1^H NMR (400 MHz, CDCl~3~): δ~H~ 5.14 (m, 3H), 3.77--3.69 (m, 1H), 3.63--3.54 (m, 1H), 3.53--3.44 (m, 2H), 3.32 (d, *J* = 4.3 Hz, 3H), 2.90 (m, 1 H), 2.52 (s, 3H); ^13^C{^1^H} NMR (50 MHz, CDCl~3~): δ~C~ 71.1, 60.2, 60.0, 59.0, 32.8; HRMS (ESI-TOF): calcd for C~5~H~14~O~2~N \[M + H\]^+^, 120.1019; found, 120.1021.

1-Tetradecanal **9**([@ref11]) {#sec4.6}
------------------------------

To a solution of 1-tetradecanol **8** (1.0 g, 4.6 mmol) in DCM (5 mL) was added bis(acetoxy)iodobenzene (1.8 g, 5.6 mmol) and TEMPO (0.07 g, 0.46 mmol), and the reaction mixture was stirred at room temperature for 3 h. The solvent was removed under reduced pressure and the residue was purified by column chromatography (silica gel, petroleum ether/EtOAc, 99:01) to yield **9** (0.93 g, 95%) as a colorless oil; *R*~f~ = 0.8 (petroleum ether). ^1^H NMR (400 MHz, CDCl~3~): δ~H~ 9.76 (s, 1H), 2.42 (t, *J* = 7.3 Hz, 2H), 1.62 (t, *J* = 7.1 Hz, 2H), 1.30--1.22 (m, 20H), 0.88 (t, *J* = 6.6 Hz, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ~C~ 202.9, 43.9, 31.9, 29.6, 29.6, 29.5, 29.4, 29.3, 29.1, 22.7, 22.1, 14.1.

Hexadec-1-en-3-ol **10**([@ref12]) {#sec4.7}
----------------------------------

To a precooled (−78 °C) solution of **9** (4.5 g, 21.1 mmol) in dry Et~2~O (30 mL) was slowly added vinyl magnesium chloride (3.75 mL, 42.3 mmol) under an argon atmosphere. The reaction mixture was stirred for 2 h at the same temperature and cautiously quenched with saturated NH~4~Cl (100 mL). The organic layer was separated, and the aqueous layer was again extracted with Et~2~O (30 mL). The combined organic layers were dried over anhydrous Na~2~SO~4~, and the solvent was removed under reduced pressure to afford a crude mixture which was purified by column chromatography (silica gel, petroleum ether/EtOAc, 97:03) to yield **10** (4.2 g, 83%) as a colorless oil; *R*~f~ = 0.7 (petroleum ether/EtOAc, 95:5). ^1^H NMR (400 MHz, CDCl~3~): δ~H~ 5.90--5.82 (m, 1H), 5.23--5.19 (d, *J* = 10.3 Hz, 1H), 5.11--5.08 (d, *J* = 10.3 Hz, 1 H), 4.09 (d, *J* = 6.4 Hz, 1H), 1.70 (br s, 1H), 1.59--1.45 (m, 2H), 1.26 (s, 22H), 0.88 (t, *J* = 6.6 Hz, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ~C~ 141.3, 114.5, 73.2, 37.0, 31.9, 29.6, 29.6, 29.5, 29.3, 25.3, 22.7, 14.1.

Ethyl (*E*)-Octadec-4-enoate **11** {#sec4.8}
-----------------------------------

A solution of **10** (0.3 g, 1.24 mmol) and triethylorthoacetate (1.5 mL, 87.34 mmol) was placed in a sealed tube and heated to 130 °C for 2 h. Excess of triethyl orthoacetate was removed by dissolving the reaction mixture in DCM (10 mL), followed by treatment with 1 M aq HCl (10 mL) solution which was stirred for 30 min. The organic layer was separated, and the aqueous layer was again extracted with DCM (15 mL). The combined organic layers were dried over anhydrous Na~2~SO~4~, and the solvent was removed under reduced pressure to afford a crude mixture which was purified by column chromatography (silica gel, petroleum ether 100%) to yield **11** (0.32 g, 84%) as a colorless oil; *R*~f~ = 0.9 (petroleum ether). ^1^H NMR (500 MHz, CDCl~3~): δ~H~ 5.50--5.36 (m, 2H), 4.13 (q, *J* = 7.1 Hz, 2H), 2.38--2.33 (m, 2H), 2.31 (t, *J* = 6.1 Hz, 2H), 2.00--1.94 (m, 2H), 1.35--1.29 (m, 4H), 1.26 (s, 21H), 0.91--0.86 (m, 3H); ^13^C{^1^H} NMR (125 MHz, CDCl~3~): δ~C~ 173.3, 131.8, 127.9, 60.2, 34.4, 32.5, 31.9, 29.7, 29.6, 29.6, 29.5, 29.4, 29.3, 29.1, 27.9, 22.7, 14.2, 14.1; HRMS (ESI-TOF): calcd for C~20~H~39~O~2~ \[M + H\]^+^, 311.2945; found, 311.2949.

(*E*)-Octadec-4-enoic Acid **12** {#sec4.9}
---------------------------------

Lithium hydroxide (0.03 g, 1.28 mmol) was added to a solution of **11** (0.25 g, 0.64 mmol) in 25 mL of ethanol/water (4:1) mixture. The resulting solution was stirred at room temperature for 1 h, then acidified with 2 N HCl to pH 1, diluted with brine, and extracted with EtOAc (2 × 15 mL). The organic phase was dried over Na~2~SO~4~, and the solvent was removed under reduced pressure to afford **12** (0.173 g, 96%) as a white solid; *R*~f~ = 0.3 (petroleum ether/EtOAc, 60:40). ^1^H NMR (400 MHz, CDCl~3~): δ~H~ 5.57--5.32 (m, 2H), 2.47--2.38 (m, 2H), 2.37--2.25 (m, 2H), 1.98 (q, *J* = 6.7 Hz, 2H), 1.26 (s, 22H), 0.89 (t, *J* = 6.6 Hz, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ~C~ 179.1, 132.2, 127.5, 34.1, 32.5, 31.9, 29.7, 29.6, 29.5, 29.4, 29.4, 29.1, 27.6, 22.7, 20.7, 14.1; HRMS (ESI-TOF): calcd for C~18~H~33~O~2~ \[M -- H\]^−^, 281.2475; found, 281.2488.

*tert*-Butyl(dec-9-en-1-yloxy)dimethylsilane **14**([@ref13]) {#sec4.10}
-------------------------------------------------------------

To a stirred solution of alcohol **13** (10.0 g, 63.99 mmol) in DCM (60 mL) was added imidazole (8.71 g, 127.98 mmol) and *tert*-butyldimethylsilyl chloride (11.57 g, 76.79 mmol) at 0 °C, and the resulting mixture was stirred at room temperature for 1 h. The reaction was quenched with a saturated aqueous solution of NH~4~Cl (40 mL), and the aqueous layer was extracted with DCM (3 × 30 mL). The combined organic layers were washed with brine, dried over Na~2~SO~4~, and concentrated in vacuo. Flash column chromatography of the crude product provided **14** (16 g, 93%) as a colorless liquid; *R*~f~ = 0.8 (petroleum ether). ^1^H NMR (400 MHz, CDCl~3~): δ~H~ 5.82 (tdd, *J* = 6.5, 10.3, 16.9 Hz, 1H), 5.03--4.97 (m, 1H), 4.94 (tdd, *J* = 1.1, 2.2, 10.2 Hz, 1H), 3.61 (t, *J* = 6.6 Hz, 2H), 2.08--2.02 (q, 2H), 1.53--1.48 (m, 2H), 1.40--1.35 (m, 2H), 1.30 (s, 8H), 0.91 (s, 9H), 0.06 (s, 6H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ~C~ 139.2, 114.1, 63.3, 33.8, 32.9, 29.5, 29.4, 29.1, 28.9, 26.0, 25.8, 18.4, −5.3.

*tert*-Butyldimethyl((8-(oxiran-2-yl)octyl)oxy)silane **15** {#sec4.11}
------------------------------------------------------------

To a stirred solution of olefin **14** (16 g, 59.14 mmol) in CH~2~Cl~2~ (100 mL) at 0 °C was added *m*-CPBA (50%, 20.41 g, 118.2 mmol). The reaction mixture was stirred at 0 °C for 12 h and then quenched by the addition of a saturated NaHCO~3~ solution (40 mL). The mixture was extracted with DCM (3 × 30 mL), and the organic layer was washed with saturated NaHCO~3~ and brine, dried over Na~2~SO~4~, and concentrated in vacuo. The crude residue was purified by flash column chromatography (petroleum ether/EtOAc, 98:2) to yield epoxide **15** (15.0 g, 88%) as a colorless liquid; *R*~f~ = 0.5 (petroleum ether/EtOAc, 95/5); ^1^H NMR (400 MHz, CDCl~3~): δ~H~ 3.59 (t, *J* = 6.6 Hz, 2H), 2.92--2.88 (m, 1H), 2.74 (dd, *J* = 4.0, 5.0 Hz, 1H), 2.46 (dd, *J* = 2.8, 5.0 Hz, 1H), 1.55--1.42 (m, 6H), 1.30 (s, 8H), 0.90 (s, 9H), 0.06 (s, 6H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ~C~ 63.2, 52.3, 47.1, 32.8, 32.5, 29.5, 29.4, 29.3, 26.0, 25.9, 25.7, 18.3, −5.3; HRMS (ESI-TOF): calcd for C~16~H~35~O~2~Si \[M + H\]^+^, 287.2401; found, 287.2399.

(*S*)-*tert*-Butyldimethyl((8-(oxiran-2-yl)octyl)oxy)silane **16a** and (*R*)-10-((*tert*-Butyldimethylsilyl)oxy)decane-1,2-diol **16b** {#sec4.12}
----------------------------------------------------------------------------------------------------------------------------------------

A solution of epoxide **15** (10.9 g, 38.26 mmol) and (*S*,*S*)-(salen)CoIII-OAc (0.2 mg, 0.306 mmol) was stirred at 0 °C for 5 min, and then distilled water (0.37 mL, 21.04 mmol, 0.55 equiv) was added. After stirring for 36 h, the mixture was concentrated, and the residue was purified by flash column chromatography (petroleum ether/EtOAc, 98:2) to afford **16a** (5.0 g, 46%) as a yellow liquid; *R*~f~ = 0.4 (petroleum ether/EtOAc, 19:1). \[α\]~D~^27^ = −3.34 (*c* 2.3 CHCl~3~); ^1^H NMR (400 MHz, CDCl~3~): δ~H~ 3.59 (t, *J* = 6.6 Hz, 2H), 2.92--2.88 (m, 1H), 2.74 (dd, *J* = 4.0, 5.0 Hz, 1H), 2.46 (dd, *J* = 2.8, 5.0 Hz, 1H), 1.55--1.42 (m, 6H), 1.30 (s, 8H), 0.90 (s, 9H), 0.06 (s, 6H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ~C~ 63.2, 52.3, 47.1, 32.8, 32.5, 29.5, 29.4, 29.3, 26.0, 25.9, 25.7, 18.3, −5.3; HRMS (ESI-TOF): calcd for C~16~H~35~O~2~Si \[M + H\]^+^, 287.2401; found, 287.2399. The chromatography was further continued to obtain diol **16b** (5.5 g, 50%) as a brown liquid (petroleum ether/EtOAc, 40:60); *R*~f~ = 0.2 (EtOAc). \[α\]~D~^27^ = +5.80 (*c* 1.0 EtOH); ^1^H NMR (400 MHz, CDCl~3~): δ~H~ 3.76--3.62 (m, 2H), 3.59 (t, *J* = 6.9 Hz, 2H), 3.42 (dd, *J* = 7.6, 10.7 Hz, 1H), 2.66 (br s, 2H), 2.04 (br s, 1H), 1.57--1.46 (m, 2H), 1.42 (br s, 3H), 1.29 (br s, 8H), 0.89 (s, 9H), 0.04 (s, 6H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ~C~ 72.3, 66.7, 63.3, 33.2, 32.8, 29.6, 29.5, 29.3, 26.0, 25.7, 25.5, 18.4, −5.3; HRMS (ESI-TOF): calcd for C~16~H~37~O~3~Si, \[M + H\]^+^, 305.2506; found, 305.2506.

(*S*)-15-((*tert*-Butyldimethylsilyl)oxy)pentadec-1-en-7-ol **17** {#sec4.13}
------------------------------------------------------------------

To a precooled (−78 °C) solution of **16a** (3.0 g, 10.47 mmol) in dry THF (20 mL) was slowly added pent-4-en-1-yl magnesium bromide (2.7 mL, 15.70 mmol) in the presence of catalytic amount of CuCl under argon atmosphere. The reaction mixture was stirred for 5 h at the same temperature and cautiously quenched with saturated NH~4~Cl (20 mL). The organic layer was separated, and the aqueous layer was again extracted with EtOAc (30 mL). The combined organic layers were dried over Na~2~SO~4~ and concentrated in vacuo. The crude residue was purified by flash column chromatography (petroleum ether/EtOAc, 93/7) to yield alcohol **17** (3.2 g, 86%) as a colorless liquid; *R*~f~ = 0.5 (petroleum ether/EtOAc, 80/20). \[α\]~D~^27^ = −1.63 (*c* 1.1 CHCl~3~); ^1^H NMR (400 MHz, CDCl~3~): δ~H~ 5.81 (tdd, *J* = 6.8, 10.3, 17.0 Hz, 1H), 5.00 (dd, *J* = 1.5, 17.1 Hz, 1H), 4.94 (td, *J* = 1.0, 10.3 Hz, 1H), 3.60 (t, *J* = 6.6 Hz, 3H), 2.14--2.02 (m, 2H), 1.55--1.34 (m, 11H), 1.30 (s, 9H), 0.91 (s, 9H), 0.05 (s, 6H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ~C~ 138.9, 114.3, 71.9, 63.3, 37.5, 37.3, 33.7, 32.9, 29.6, 29.6, 29.4, 29.1, 28.9, 26.0, 25.8, 25.7, 25.6, 25.1, 18.4, −5.3; HRMS (ESI-TOF): calcd for C~21~H~44~O~2~SiNa \[M + Na\]^+^, 379.3003; found, 379.3000.

(*S*)-Pentadec-14-ene-1,9-diol **18** {#sec4.14}
-------------------------------------

A solution of TBAF (1 M in THF, 10.3 mL, 10.51 mmol) was added to a stirred solution of compound **17** (2.5 g, 7.0 mmol) in THF (20 mL) at 0 °C. The resulting mixture was stirred at room temperature for 6 h and then diluted with water. The mixture was extracted with EtOAc (3 × 10 mL), and the organic layer was washed with water, dried over Na~2~SO~4~, and concentrated under reduced pressure. The crude product was purified by flash column chromatography (petroleum ether/EtOAc, 85/15) to provide compound **18** (1.7 g, 99%) as a white solid; *R*~f~ = 0.2 (petroleum ther/EtOAc, 80/20). \[α\]~D~^27^ = +0.23 (*c* 1.5 CHCl~3~); mp = 42--44 °C; ^1^H NMR (400 MHz, CDCl~3~): δ~H~ 5.86--5.74 (m, 1H), 5.03--4.96 (m, 1H), 4.96--4.89 (m, 1H), 3.62 (t, *J* = 6.9 Hz, 3H), 3.57 (dd, *J* = 3.8, 6.9 Hz, 1H), 2.06 (q, *J* = 6.1 Hz, 2H), 1.60--1.51 (m, 4H), 1.47--1.37 (m, 10H), 1.30 (m, 7H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ~C~ 138.9, 114.3, 71.9, 63.3, 37.5, 37.3, 33.7, 32.9, 29.6, 29.6, 29.4, 29.1, 28.9, 26.0, 25.8, 25.7, 25.6, 25.1, 18.4, −5.3; HRMS (ESI-TOF): calcd for C~15~H~30~O~2~Na \[M + Na\]^+^, 265.2138; found, 265.2137.

(*R*)-7,15-Dichloropentadec-1-ene **19** {#sec4.15}
----------------------------------------

To a solution of diol **18** (1.5 g, 6.18 mmol) in CCl~4~ (30 mL) was added PPh~3~ (4.5 g, 17.32 mmol) at room temperature under argon atmosphere, and the mixture was stirred at 100 °C for 48 h. After the completion of reaction, the mixture was allowed to cool at room temperature, and then diluted with DCM (20 mL) and concentrated under reduced pressure. The crude product was purified by flash column chromatography (petroleum ether) to provide compound **19** (1.3 g, 76%) as a colorless liquid; *R*~f~ = 0.9 (petroleum ether). \[α\]~D~^27^ = +2.80 (*c* 0.49 CHCl~3~); ^1^H NMR (400 MHz, CDCl~3~): δ~H~ 5.81 (tdd, *J* = 6.7, 10.3, 17.1 Hz, 1H), 5.05--4.90 (m, 2H), 3.89 (tt, *J* = 5.2, 7.7 Hz, 1H), 3.54 (t, *J* = 6.6 Hz, 2H), 2.11--2.03 (m, 2H), 1.81--1.67 (m, 6H), 1.58--1.49 (m, 2H), 1.46--1.37 (m, 6H), 1.32 (m, 6H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ~C~ 138.9, 114.3, 71.9, 62.9, 37.4, 37.2, 33.7, 32.7, 29.6, 29.5, 29.3, 28.9, 25.7, 25.6, 25.1; HRMS (ESI-TOF): calcd for C~15~H~28~Cl~2~Na \[M + Na\]^+^, 301.1460; found, 301.1413.

(*R*,*E*)-10,18-Dichlorooctadec-4-enoic Acid **21** {#sec4.16}
---------------------------------------------------

Grubbs second generation catalyst (0.09 g, 0.10 mmol, 0.05 equiv), 4-pentenoic acid 20 (0.042 g, 0.42 mmol), and dichloro alkene **19** (0.6 g, 2.15 mmol) were dissolved in degassed CH~2~Cl~2~ (150 mL), and the reaction mixture was heated at 40 °C for 12 h. After this time, the solvent was removed under reduced pressure and the resulting crude product was purified by flash column chromatography (petroleum ether/EtOAc, 92:8) to afford **21** (0.135 g, 92%) as a colorless liquid; *R*~f~ = 0.24 (petroleum ether/EtOAc, 80:20). \[α\]~D~^27^ = +1.59 (*c* 0.62 CHCl~3~); ^1^H NMR (400 MHz, CDCl~3~): δ~H~ 5.48--5.42 (td, *J* = 5.7, 16.0 Hz, 2H), 3.88 (t, *J* = 5.3 Hz, 1H), 3.54 (t, *J* = 6.9 Hz, 2H), 2.45--2.38 (m, 3H), 2.36--2.30 (m, 2H), 2.05--1.94 (m, 2H), 1.81--1.74 (m, 2H), 1.74--1.66 (m, 4H), 1.46--1.36 (m, 6H), 1.32 (m, 8H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ~C~ 179.4, 131.6, 127.9, 64.2, 45.1, 38.5, 38.3, 34.1, 32.6, 32.3, 29.7, 29.3, 29.0, 28.8, 27.5, 26.8, 26.4, 25.9; HRMS (ESI-TOF): calcd for C~18~H~31~O~2~Cl~2~ \[M -- H\]^−^, 349.1696; found, 349.1698.

Serinolamide A (*R*,*E*)-*N*-(1-Hydroxy-3-methoxypropan-2-yl)-*N*-methyloctadec-4-enamide **1** {#sec4.17}
-----------------------------------------------------------------------------------------------

To a solution of (*R*)-**7** (0.084 g, 0.7 mmol) in DCM (3 mL) was added **11** (0.2 g, 0.7 mmol) dissolved in DCM (5 mL), EDC (0.13 g, 0.85 mmol), HOBt (0.14 g, 0.85 mmol), and DIPEA (0.3 mL, 1.7 mmol) at 0 °C. The reaction mixture was warmed to room temperature and stirred for 12 h. After the completion of the reaction (indicated by TLC), more DCM (10 mL) was added and the mixture was washed with water (5 mL) and brine (5 mL). The organic layer was dried over anhydrous Na~2~SO~4~, concentrated under reduced pressure, and purified by column chromatography (silica gel, PE/EtOAc, 40:60) to yield **1** (0.2 g, 75%) as a colorless oil; *R*~f~ = 0.5 (EtOAc). ee \> 99% \[the ee was determined by chiral HPLC analysis: CHIRALPAK-IA (150 × 4.6 mm) column; eluent: *n*-hexane/ethanol (95:05), flow rate---1.0 mL/min, detector: 210 nm, \[(*R*)-isomer---*t*~R~: 6.85 min; (*S*)-isomer---*t*~R~: 10.28 min\]; \[α\]~D~^25^ = −2.8 (*c* 0.18, CHCl~3~) {lit.^[@ref5]^ \[α\]~D~^25^ = +1.97 (*c* 0.18, CHCl~3~)}; ^1^H NMR (400 MHz, CDCl~3~): δ~H~ 5.45 (d, *J* = 4.9 Hz, 2H), 3.81--3.70 (m, 2H), 3.65--3.63 (m, 1H), 3.57--3.56 (dd, 1H), 3.47--3.46 (d, 1H), 3.33 (s, 3H), 3.01 (s, 2H), 2.83 (s, 1H), 2.51--2.36 (m, 2H), 2.36--2.24 (m, 2H), 1.96 (d, *J* = 5.9 Hz, 2H), 1.25 (s, 22H), 0.88 (t, *J* = 6.6 Hz, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ~C~ 174.4, 131.6, 128.4, 70.9, 61.9, 60.8, 58.9, 57.4, 34.2, 33.5, 32.5, 31.9, 29.7, 29.6, 29.5, 29.3, 29.2, 28.3, 28.0, 22.7, 14.1; HRMS (ESI-TOF): calcd for C~23~H~45~O~3~NNa \[M + Na\]^+^, 406.3292; found, 406.3280.

Columbamide D ((*R*,*E*)-10,18-Dichloro-*N*-((*R*)-1-hydroxy-3-methoxypropan-2-yl)-*N*-methyloctadec-4-enamide) **2** {#sec4.18}
---------------------------------------------------------------------------------------------------------------------

To a solution of (*R*)-**7** (0.034 g, 0.28 mmol) in DCM (3 mL) was added **21** (0.1 g, 0.28 mmol) dissolved in DCM (5 mL), EDC (0.053 g, 0.34 mmol), HOBt (0.046 g, 0.34 mmol), and DIPEA (0.2 mL, 0.7 mmol) at 0 °C. The reaction mixture was warmed to room temperature and stirred for 12 h. After the completion of the reaction (indicated by TLC), more DCM (10 mL) was added and the mixture was washed with water (5 mL) and brine (5 mL). The organic layer was dried over anhydrous Na~2~SO~4~, concentrated under reduced pressure, and purified by column chromatography (petroleum ether/EtOAc, 30:70) to afford **2** (0.09 g, 71%) as a colorless liquid; *R*~f~ = 0.4 (EtOAc). \[α\]~D~^24^ = −4.56 (*c* 0.39 CHCl~3~) {lit.^[@cit3a]^ \[α\]~D~^25^ = −4.6 (*c* 0.39, CHCl~3~)}; ^1^H NMR (400 MHz, CDCl~3~): δ~H~ 5.46 (t, *J* = 2.7 Hz, 2H), 4.48--4.37 (m, 1H), 3.94--3.85 (m, 1H), 3.82--3.71 (m, 2H), 3.70--3.58 (m, 1H), 3.57--3.45 (m, 3H), 3.35 (s, 3H), 3.01 (s, 2H), 2.84 (s, 1H), 2.50--2.38 (m, 2H), 2.33 (dd, *J* = 3.4, 7.2 Hz, 2H), 2.15--2.02 (m, 1H), 2.00 (d, *J* = 4.6 Hz, 2H), 1.80--1.67 (m, 6H), 1.49--1.27 (m, 14H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ~C~ 174.3, 131.1, 128.9, 70.9, 64.3, 62.1, 59.0, 57.5, 45.2, 38.5, 38.3, 34.2, 33.6, 32.6, 32.3, 29.3, 29.0, 28.9, 28.8, 28.0, 26.8, 26.4, 26.0; HRMS (ESI-TOF): calcd for C~23~H~44~O~3~NCl~2~ \[M + H\]^+^, 452.2693; found, 452.2690.
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